---
title: Share capital increase registered 12. Jul 2018
description: Reference is made to the stock exchange notice from Gentian Diagnostics AS (the
---

Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 15 June 2018 regarding a private placement towards Vatne Equity AS and Norron AB, by issuance of 1,399,628 new shares in the Company at a subscription price of NOK 50 per new share.

The share capital increase pertaining to the private placement is now registered with the Norwegian Register of Business Enterprises. The Company's new registered share capital is NOK 1,539,592.10 divided on 15,395,921 shares, each with a nominal value of NOK 0.10.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

**For more information, please contact:**

Njaal Kind  
 Group CFO, Gentian Diagnostics AS  
[njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)  
 +47 9190 6525

 

**MeldingsID**: 455507  
**UtstederID:** GENT-ME  
**Instrument:** GENT-ME  
**Marked:** Merkur Market  
**Kategori:** KAPITAL- OG STEMMERETTSENDRINGER  
**Informasjonspliktige opplysninger:** Ja

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/share-capital-increase-registered#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/share-capital-increase-registered#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/share-capital-increase-registered#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)